PIA
AMRX icon

Piedmont Investment Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

Piedmont Investment Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,509
Closed -$25K – 1096
2018
Q2 		$25K Buy
+1,509
New +$26.5K ﹤0.01% 1513

Other funds holding AMRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Piedmont Investment Advisors's AMRX Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Amneal Pharmaceuticals (AMRX) in Q3 2018, closing a stake of 1,509 shares — an estimated $25K sold.

Piedmont Investment Advisors first reported a position in AMRX in Q2 2018 and held it in 1 quarter. The position peaked at $25K in Q2 2018. 167 funds tracked by Wall St. Rank hold AMRX as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Amneal Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 1,509 Amneal Pharmaceuticals shares in Q3 2018, an estimated $25K.
  • Piedmont Investment Advisors first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Amneal Pharmaceuticals position peaked at $25K in Q2 2018.
  • 167 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.